News
 

Is fecal microbiota transplantation (FMT) safe and does it improve symptoms in Parkinson disease (PD)?

Multiple Sclerosis (MS) is a complex neurological disease which prevalence is increasing worldwide. The impact of environmental factors on MS susceptibility has already been defined and highlighted in many previous reports, particularly vitamin D or ultraviolet B light exposure, Epstein-Barr virus (EBV) infection, obesity, and smoking. There is...

Alzheimer's disease is the most common cause of dementia, affecting about 35 million people worldwide, and the number is growing.

Researchers at the Medical College of Georgia at Augusta University are investigating why many men with prostate cancer develop Alzheimer's disease (AD), focusing on whether androgen deprivation therapy (ADT) or an overactive immune response contributes to this risk.

A new study explores how the brain responds to various forms of love, from parental to romantic, using advanced imaging techniques.

Enhancing prefrontal cortex (PFC) cognitive functions requires identifying suitable exercises that increase cerebral blood flow.

Recent research from Washington University School of Medicine in St. Louis reveals that people with multiple sclerosis (MS) are significantly less likely to develop Alzheimer's disease compared to those without MS. This finding opens a new path for Alzheimer's research.

A recent study reveals that COVID-19 vaccination does not increase the risk of relapse in most patients with multiple sclerosis (MS). However, there is a slight rise in relapse risk following a COVID-19 booster in patients with high MS activity.

A new study finds that 40Hz light and sound therapy helps maintain myelin, a crucial brain structure, in Alzheimer's patients. This therapy, which protects neurons and supports brain function, could offer new treatment avenues for neurodegenerative diseases.

How well do visual reads and quantitative assessments of tau positron emission tomography (PET) predict clinical progression from mild cognitive impairment (MCI) to dementia compared to amyloid-β (Aβ) PET and magnetic resonance imaging (MRI)?